secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001779128-24-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q4 revenue up 24.5% to $47.5M; guides for 2024 Adj. EBITDA profitability
------------------------------------------------------------------------------

- Q4 revenue $47.5M (+24.5% YoY); full year revenue $225.2M (+54.1%).
- Net loss widened to $(33.9)M in Q4 from $(15.4)M; Adj. EBITDA improved to $(5.2)M from $(8.0)M.
- Full year 2023 Adj. EBITDA $(16.6)M; guides for 2024 Adj. EBITDA profitability and 2025 double-digit millions.
- Announced pending purchase of eight jet aircraft to support Medical growth; new organ placement service launched.
- Medical segment Adj. EBITDA positive $2.5M in Q4, up 57.8% YoY; Passenger Adj. EBITDA loss improved to $(2.6)M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/0001779128-24-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/blde-20240312.htm
  HTML page:      https://secwatch.observer/filing/0001779128-24-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer